Guided Therapeutics (GTHP) Other Non-Current Assets (2016 - 2025)
Guided Therapeutics (GTHP) reported Other Non-Current Assets of $17000.0 for Q4 2025, little changed on a YoY basis from $17000.0 in Q4 2024, and little changed sequentially from $17000.0 in Q3 2025.
Guided Therapeutics (GTHP) Other Non-Current Assets (2016 - 2025) Analysis & Trends
Guided Therapeutics (GTHP) has 10 years of Other Non-Current Assets data on file, last reported at $17000.0 in Q4 2025.
- For the quarter ending Q4 2025, Other Non-Current Assets changed 0.0% year-over-year to $17000.0; the trailing twelve-month figure through Dec 2025 stood at $17000.0 (changed 0.0% YoY), and the FY2025 full-year result was $17000.0, changed 0.0% from the prior year.
- Other Non-Current Assets steadied at $17000.0 in Q4 2025, from $17000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $18000.0 in Q1 2021 to a low of $17000.0 in Q2 2021.
- A 5-year average of $17050.0 and a median of $17000.0 in 2021 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets rose 5.88% in 2021 and decreased 5.56% in 2022, its largest moves.
- Tracing GTHP's Other Non-Current Assets over 5 years: stood at $17000.0 in 2021, then changed by 0.0% to $17000.0 in 2022, then changed by 0.0% to $17000.0 in 2023, then changed by 0.0% to $17000.0 in 2024, then changed by 0.0% to $17000.0 in 2025.
- Business Quant data shows GTHP's Other Non-Current Assets at $17000.0 in Q4 2025, $17000.0 in Q3 2025, and $17000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 2.05 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 285.90 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 828.89 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 164.00 Mn |
| 10 | Guided Therapeutics | 21.96 Mn | 21.89 Mn | 458,000.00 | 17,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 17,000.00 |
| Sep 30, 2025 | 17,000.00 |
| Jun 30, 2025 | 17,000.00 |
| Mar 31, 2025 | 17,000.00 |
| Dec 31, 2024 | 17,000.00 |
| Sep 30, 2024 | 17,000.00 |
| Jun 30, 2024 | 17,000.00 |
| Mar 31, 2024 | 17,000.00 |
| Dec 31, 2023 | 17,000.00 |
| Sep 30, 2023 | 17,000.00 |
| Jun 30, 2023 | 17,000.00 |
| Mar 31, 2023 | 17,000.00 |
| Dec 31, 2022 | 17,000.00 |
| Sep 30, 2022 | 17,000.00 |
| Jun 30, 2022 | 17,000.00 |
| Mar 31, 2022 | 17,000.00 |
| Dec 31, 2021 | 17,000.00 |
| Sep 30, 2021 | 17,000.00 |
| Jun 30, 2021 | 17,000.00 |
| Mar 31, 2021 | 18,000.00 |